Croatia vs Lithuania: HICP - Tea, mate and other plant-derived products for infusion (ND)
Croatia
1.72
in 2026
Lithuania
1.89
in 2026
Croatia rank
5th
Lithuania rank
3rd
HICP - Tea, mate and other plant-derived products for infusion (ND) over time
- Croatia
- Lithuania
How they compare
Lithuania currently reports 1.89 against 1.72 in Croatia, a difference of 0.17.
That makes Lithuania's figure about 1.1 times Croatia's.
The two have swapped places 7 times across 29 shared years of data; in 1998 it was Croatia ahead.
Croatia ranks 5th and Lithuania ranks 3rd of 27 countries.
Across the 4 decades both report, Croatia averaged higher in 1 and Lithuania in 3.
Head to head by decade
| Decade | Croatia | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 1.41 | 2.16 | 0.75 | Lithuania |
| 2000s | 1.26 | 2.63 | 1.37 | Lithuania |
| 2010s | 2.32 | 2.15 | 0.168 | Croatia |
| 2020s | 1.84 | 2.03 | 0.1871 | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hicp - tea, mate and other plant-derived products for infusion (nd), Croatia or Lithuania?
- Lithuania, at 1.89 against 1.72 in Croatia as of 2026.
- What is the difference in hicp - tea, mate and other plant-derived products for infusion (nd) between Croatia and Lithuania?
- 0.17, with Lithuania ahead.
- How many years of comparable data are there for Croatia and Lithuania?
- 29 years are reported by both, from 1998 to 2026.
- How do Croatia and Lithuania rank globally for hicp - tea, mate and other plant-derived products for infusion (nd)?
- Croatia ranks 5th and Lithuania ranks 3rd of 27 countries.
- Where does this data come from?
- European Central Bank, published as HICP - Tea, mate and other plant-derived products for infusion (ND) (Neither seasonally nor working day adjusted, Sub-index weight). Statizoid refreshes it automatically from the source and publishes the full history for both places.